These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34348326)

  • 1. Clinical Features and Prognosis of Patients with Carcinoid Syndrome and Carcinoid Heart Disease: A Retrospective Multicentric Study of 276 Patients.
    Fijalkowski R; Reher D; Rinke A; Gress TM; Schrader J; Baum RP; Kaemmerer D; Hörsch D
    Neuroendocrinology; 2022; 112(6):547-554. PubMed ID: 34348326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of midgut carcinoid tumors and carcinoid syndrome.
    van der Horst-Schrivers AN; Wymenga AN; Links TP; Willemse PH; Kema IP; de Vries EG
    Neuroendocrinology; 2004; 80 Suppl 1():28-32. PubMed ID: 15477713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoid heart disease. A unique case of postvalvotomy diagnosis.
    Kessler MR
    Arch Intern Med; 1983 Aug; 143(8):1615-6. PubMed ID: 6870445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoid syndrome-Symptoms and therapeutic approaches.
    Chrisoulidou A
    Hell J Nucl Med; 2023; 26 Suppl():52-56. PubMed ID: 37658565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-dimensional echocardiography in the diagnosis of carcinoid heart disease.
    Forman MB; Byrd BF; Oates JA; Robertson RM
    Am Heart J; 1984 Mar; 107(3):492-6. PubMed ID: 6695693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carcinoid heart disease].
    Bencze A; Szücs N; Igaz P; Leiszter K; Nagy Z; Patócs A; Rácz K
    Orv Hetil; 2013 Apr; 154(14):546-50. PubMed ID: 23545233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of peptide receptor radiotargeted therapy in relation to cardiac valve surgery for carcinoid heart disease in patients with neuroendocrine metastases and cardiac syndrome. A single-centre study from a centre of excellence.
    Davis LM; Nicou N; Martin W; Corcoran B; Mulholland N; Srirajaskanthan R; Ramage J; Wendler O; Vivian G
    Nucl Med Commun; 2020 Jun; 41(6):575-581. PubMed ID: 32371675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Echocardiographic detection of tricuspid insufficiency in carcinoid heart syndrome - case report].
    Polster J; Klapdor R; Langenstein BA; Hanrath P
    Z Kardiol; 1982 Oct; 71(10):689-90. PubMed ID: 7157923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of somatostatin analog in management of carcinoid syndrome.
    Vinik A; Moattari AR
    Dig Dis Sci; 1989 Mar; 34(3 Suppl):14S-27S. PubMed ID: 2920654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoid syndrome. Medical management.
    Clarke B; Hodgson HJ
    Br J Hosp Med; 1986 Mar; 35(3):146-8, 150, 152. PubMed ID: 3742126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.
    Kostiainen I; Karppinen N; Simonen P; Rosengård-Bärlund M; Lindén R; Tarkkanen M; Gordin D; Rapola J; Schalin-Jäntti C; Matikainen N
    Endocrine; 2022 Jun; 77(1):177-187. PubMed ID: 35536452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome.
    Zandee WT; Brabander T; Blažević A; Minczeles NS; Feelders RA; de Herder WW; Hofland J
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3665-e3672. PubMed ID: 33942075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing features of idiopathic flushing and carcinoid syndrome.
    Aldrich LB; Moattari AR; Vinik AI
    Arch Intern Med; 1988 Dec; 148(12):2614-8. PubMed ID: 2461688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carcinoid syndrome as a cause of right ventricular failure. Diagnosis with x-ray computed tomography and magnetic resonance imaging].
    Sinitsyn VE; Nagornyĭ MN; Veselova TN; Stukalova OV; Dzemeshkevich SL; Agapov AA; Ternovoĭ SK
    Kardiologiia; 2002; 42(10):102-4. PubMed ID: 12494064
    [No Abstract]   [Full Text] [Related]  

  • 15. Palliation of carcinoid heart disease.
    Codd JE; Drozda J; Merjavy J
    Arch Surg; 1987 Sep; 122(9):1076-7. PubMed ID: 3619623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carcinoid heart disease secondary to a tumor of the small intestine. Apropos of a case with associated tricuspid and pulmonary insufficiency].
    Rossignol B; Machecourt J; Denis B; Roche J; N'Golet A; Morena H; Martin-Noël P
    Arch Mal Coeur Vaiss; 1977 Nov; 70(11):1221-6. PubMed ID: 146456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tricuspid insufficiency in carcinoid heart disease: an echocardiographic description.
    Baker BJ; McNee VD; Scovil JA; Bass KM; Watson JW; Bissett JK
    Am Heart J; 1981 Jan; 101(1):107-8. PubMed ID: 7457331
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review study.
    Strosberg JR; Benson AB; Huynh L; Duh MS; Goldman J; Sahai V; Rademaker AW; Kulke MH
    Oncologist; 2014 Sep; 19(9):930-6. PubMed ID: 25096997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study.
    Halperin DM; Shen C; Dasari A; Xu Y; Chu Y; Zhou S; Shih YT; Yao JC
    Lancet Oncol; 2017 Apr; 18(4):525-534. PubMed ID: 28238592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross sectional echocardiographic feature in carcinoid heart disease. A mechanism for tricuspid regurgitation in this syndrome.
    Davies MK; Lowry PJ; Littler WA
    Br Heart J; 1984 Mar; 51(3):355-7. PubMed ID: 6696814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.